The Author's Reply to "Did This Cryptococcosis Patient Have HIV Coinfection?"
| Errataetall: |
CommentOn: Intern Med. 2019 Mar 15;58(6):843-847. - PMID 30449801 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
|---|---|
| Enthalten in: |
Internal medicine (Tokyo, Japan) - 58(2019), 24 vom: 15. Dez., Seite 3621 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sato, Shuku [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4Z63YK6E0E |
|---|
| Anmerkungen: |
Date Completed 18.12.2019 Date Revised 11.01.2020 published: Print-Electronic CommentOn: Intern Med. 2019 Mar 15;58(6):843-847. - PMID 30449801 Citation Status MEDLINE |
|---|
| doi: |
10.2169/internalmedicine.3421-19 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM30002102X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM30002102X | ||
| 003 | DE-627 | ||
| 005 | 20231225101621.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2169/internalmedicine.3421-19 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1000.xml |
| 035 | |a (DE-627)NLM30002102X | ||
| 035 | |a (NLM)31391397 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sato, Shuku |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Author's Reply to "Did This Cryptococcosis Patient Have HIV Coinfection?" |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.12.2019 | ||
| 500 | |a Date Revised 11.01.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Intern Med. 2019 Mar 15;58(6):843-847. - PMID 30449801 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a HIV | |
| 650 | 4 | |a cryptococcosis | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a daratumumab |2 NLM | |
| 650 | 7 | |a 4Z63YK6E0E |2 NLM | |
| 650 | 7 | |a Dexamethasone |2 NLM | |
| 650 | 7 | |a 7S5I7G3JQL |2 NLM | |
| 650 | 7 | |a Lenalidomide |2 NLM | |
| 650 | 7 | |a F0P408N6V4 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Internal medicine (Tokyo, Japan) |d 1996 |g 58(2019), 24 vom: 15. Dez., Seite 3621 |w (DE-627)NLM012606731 |x 1349-7235 |7 nnns |
| 773 | 1 | 8 | |g volume:58 |g year:2019 |g number:24 |g day:15 |g month:12 |g pages:3621 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2169/internalmedicine.3421-19 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 58 |j 2019 |e 24 |b 15 |c 12 |h 3621 | ||